Spaceflight-associated neuro-ocular syndrome a potential challenge during long missions.
Advances in treatment and surgical techniques have transformed patient care.
This research was a finalist in the 2020 Ophthalmology Times® Research Scholar Honoree Program.
Physicians can discover, diagnose, document, treat diseases that might go undetected
For health care workers, the pandemic has led to increased burnout, concerns about workplace safety, and staffing shortages that threaten not only patient care but also the entire provider ecosystem.
First new therapy in nearly a decade offers another option for physicians, patients
Future investigations will assess findings, evaluate their prognostic value.
The project, presented by Colton Hill, MPH, on behalf of the Dean McGee Eye Institute, looks at complication rates during cataract surgery or after cataract surgery for patients with prior intravitreal injections or incisional retinal procedures.
Optics block out-of-focus and stray light, allow continuum of vision.
Unique clinical trials and novel products of interest currently under investigation for the treatment of dry eye disease.
Physicians can use navigational tools to attain a much more immersive perspective.
Lens thickness and anterior chamber duct values obtained by Lenstar can be improved by SpikeFinder to reduce errors in measurements.
Papilledema with back pain suggests spine lesion.
Having a comprehensive team of ophthalmic specialists in place means patients could have multiple issues treated in a single procedure that might require two surgeries otherwise.
Adolf Fercher's 2D image of fundus paved way for today’s imaging technique.
Nasotemporal sagittal height asymmetry a good biomarker of shortsightednes.
As dexamethasone adds indications, a study confirms efficacy of punctal occlusion for allergic conjunctivitis.
When it comes to the sexes in the operating room, the key is collaboration, with a goal of presenting patient suffering.
Higher levels of 3 macular pigments minimize risk of age-related disease.
Carl D. Regillo, MD, and Jennifer I. Lim, MD, emphasize the high regulatory standards of equivalence and safety of biosimilars in considering the role they will play in the evolving treatment landscape for retinal disorders.
Drops can simplify dosing, improving adherence and ocular surface health
According to Nicole Fram, MD, around the world, corneal specialists are making the most of limited resources.
Expert panelists provide an overview of current unmet needs in wet AMD care and discuss the potential for improving clinical outcomes and treatment burden.
Unique clinical trials and novel products of interest currently under investigation for the treatment of dry eye disease.
Joseph Panarelli, MD, and Arsham Sheybani, MD, discuss the Primary Trabeculectomy for Advanced Glaucoma: Pragmatic Multicentre Randomized Controlled Trial, or TAGS trial, and how this can apply to real world situation. This multicenter randomized controlled trial evaluated whether primary trabeculectomy or primary medical treatment leads to improved outcomes in terms of quality of life, clinical effectiveness, and safety.